Apple TV+ has set Friday, August 1 for the premiere of Jason Momoa‘s new historical drama series Chief of War. The series will launch with its first two episodes, followed by new episodes every ...

A number of congressional Republicans are publicly voicing concern over the potential for a prolonged trade war and its effect on American farmers as President Donald Trump prepares to announce a ...

Several moments of the film are appreciably harrowing – but on the whole the film is mired in the same war fetishization that ... face blurred in an accidental nod to the preceding, mind-numbing ...

Based on an actual incident from the Iraq War, Warfare is an especially effective and visceral depiction of modern combat. Only those who were there can say whether it’s a 100% realistic ...

Seager (calf) will start at designated hitter and will bat second in Thursday's season opener versus the Red Sox. Though Seager's availability for Opening Day wasn't in much doubt after he took ...

As such, it's not impossible that Vejmelka gets the nod again versus Tampa Bay on Friday, but it could be an opportunity for Jaxson Stauber to get into a game.

Koraput: State govt has approved the geographic information system and remote sensing (GIS/RS)-based master plan for Jeypore town, nearly eight months after its draft was submitted to the housing ...

Her lawyer, Gregory Romanovsky, said Petrova is fighting the possible deportation back to Russia for fear of persecution and jail time over her protests decrying the Ukraine war. On Feb. 16 ...

These are the key events on day 1,130 of Russia’s war on Ukraine. These are the key developments on day 1,129 of Russia’s war on Ukraine.

Blackstone-backed ASK Asset & Wealth Management Group has received in-principle approval from the Securities and Exchange Board of India (SEBI) to start its mutual fund business. ASK plans to ...

His ultimate goal is to have an army larger than America's, our Moscow correspondent explains. Follow the latest below, and submit your questions for our next war Q&A.

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 results. The company achieved a significant milestone with the FDA’s ...